98
Views
4
CrossRef citations to date
0
Altmetric
Clinical Focus: Diabetes

A Comparison of the Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination Therapy with Irbesartan Monotherapy in the Treatment of Moderate or Severe Hypertension in Diabetic and Obese Hypertensive Patients: A Post-Hoc Analysis Review

, MD
Pages 126-134 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Guido Grassi. (2016) Lercanidipine/enalapril combination in the management of obesity-related hypertension. Integrated Blood Pressure Control 9, pages 69-77.
Read now

Articles from other publishers (3)

Jie Peng, Yingxin Zhao, Hua Zhang, Zhendong Liu, Zhihao Wang, Mengxiong Tang, Ming Zhong, Fanghong Lu & Wei Zhang. (2014) Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure. Hypertension Research 38:2, pages 123-131.
Crossref
Xiangjun Qiu, Zhe Wang, Bing Wang, Hui Zhan, Xiaofeng Pan & Ren-ai Xu. (2014) Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by ultra high performance liquid chromatography tandem mass spectrometry and its application to a bioequivalence study. Journal of Chromatography B 957, pages 110-115.
Crossref
Qi-Fang Huang, Chang-Sheng Sheng, Yan Li, Gen-Shan Ma, Qiu-Yan Dai & Ji-Guang Wang. (2013) Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension. Drugs in R&D 13:2, pages 109-117.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.